selected publications
- Multifocal and pathologically-confirmed brain metastasis complete response to trastuzumab deruxtecan. CNS oncology. 2022 Academic Article GET IT
- Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force. Transplantation and cellular therapy. 2022 Review GET IT
- Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies. Blood cancer journal. 2022 Academic Article GET IT
-
Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells.
Blood advances.
2021
Academic Article
GET IT
Times cited: 85 - Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2021 Academic Article GET IT
-
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors.
Journal for immunotherapy of cancer.
2021
Academic Article
GET IT
Times cited: 109 -
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.
Journal for immunotherapy of cancer.
2021
Academic Article
GET IT
Times cited: 421 - Neurotoxicity Biology and Management. Cancer journal (Sudbury, Mass.). 2021 Review GET IT
-
Clinical trial of proton craniospinal irradiation for leptomeningeal metastases.
Neuro-oncology.
2021
Academic Article
GET IT
Times cited: 65 -
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients.
Cancer cell.
2021
Academic Article
GET IT
Times cited: 52 -
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma.
Haematologica.
2021
Letter
GET IT
Times cited: 43 -
The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy.
Transplantation and cellular therapy.
2020
Academic Article
GET IT
Times cited: 31 -
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events.
Journal for immunotherapy of cancer.
2020
Academic Article
GET IT
Times cited: 171 -
Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies.
Blood advances.
2020
Academic Article
GET IT
Times cited: 189 -
Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma.
Blood cancer journal.
2020
Academic Article
GET IT
Times cited: 153 - Reply. Ophthalmology. 2020 Article GET IT
-
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality.
Blood advances.
2020
Academic Article
GET IT
Times cited: 90 -
Anticancer Drugs and the Nervous System.
Continuum (Minneapolis, Minn.).
2020
Review
GET IT
Times cited: 5 -
Immune Checkpoint Inhibitor-Associated Optic Neuritis.
Ophthalmology.
2020
Academic Article
GET IT
Times cited: 7 -
Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management.
Blood advances.
2020
Academic Article
GET IT
Times cited: 113 -
MRI radiomic features are associated with survival in melanoma brain metastases treated with immune checkpoint inhibitors.
Neuro-oncology.
2019
Academic Article
GET IT
Times cited: 46 - The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2019 Review GET IT
-
Electrophysiological findings in immune checkpoint inhibitor-related peripheral neuropathy.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology.
2019
Academic Article
GET IT
Times cited: 46 - Reply. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Letter GET IT
-
Clinical and Biological Correlates of Neurotoxicity Associated with CAR T-cell Therapy in Patients with B-cell Acute Lymphoblastic Leukemia.
Cancer discovery.
2018
Academic Article
GET IT
Times cited: 638 -
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.
The New England journal of medicine.
2018
Academic Article
GET IT
Times cited: 1948 -
T cells presenting viral antigens or autoantigens induce cytotoxic T cell anergy.
JCI insight.
2017
Academic Article
GET IT
Times cited: 3 -
T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.
European journal of immunology.
2014
Academic Article
GET IT
Times cited: 28 - Temporal lobe meningioma with ipsilateral herpes simplex encephalitis. The Neurohospitalist. 2014 Academic Article GET IT
-
Tolerance to the neuron-specific paraneoplastic HuD antigen.
PloS one.
2009
Academic Article
GET IT
Times cited: 26 -
G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Nature.
1998
Academic Article
GET IT
Times cited: 724